| Financial Year |
March 31 2023 |
| Monetary Funds |
1,596,477,519.43 |
| Held-for-trading Financial Assets |
7,000,000.00 |
| Notes Receivable |
4,750,000.00 |
| Accounts Receivable |
339,042,181.44 |
| Advances to Suppliers |
30,689,369.90 |
| Other Receivables |
23,732,656.62 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,831,286,281.23 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
18,936,518.68 |
| Total Current Assets |
3,851,914,527.30 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
540,610,913.75 |
| Investment Properties |
2,905,299.90 |
| Fixed Assetes |
158,055,528.49 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
46,487,845.03 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
26,826,074.69 |
| Deferred Income Tax Assets |
16,008,395.32 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
821,815,919.78 |
| Total Assets |
4,673,730,447.08 |
| Short-Term Loans |
515,249,486.11 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
144,169,502.33 |
| Accounts Received In Advance |
1,324,620.40 |
| Employee Compensation Payable |
7,506,305.07 |
| Taxes Payable |
25,808,604.71 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
20,361,182.25 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
8,955,820.83 |
| Other Current Liabilities |
838,903,006.48 |
| Sub-Total of Current Liabilities |
1,571,148,388.80 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
76,361,018.63 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
108,471,756.92 |
| Total Liabilities |
1,679,620,145.72 |
| Paid-In Capital(Or Share Stock) |
528,000,000.00 |
| Capital Surplus |
1,651,026,909.37 |
| Surplus Reserve |
117,941,106.18 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
675,592,384.53 |
| Minority Stockholder's Interest |
16,734,177.28 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,977,376,124.08 |
| Owner's Equity（Stockholder's Equity） |
2,994,110,301.36 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
4,673,730,447.08 |
